Evidence of myocardial infarction during the follow up was
present in 267 of the participants in the total cohort and in 42
of the 100 patients with HF. Five of the patients with HF
presented in the immediate post-infarct period (within 30
days after the myocardial infarction). After adjustment for
interim myocardial infarction in addition to the established
baseline risk factors for HF, metabolic syndrome remained a
significant predictor of subsequent HF (table 3, model C).